Library | SASB Sustainability Sector
Health Care
Refine
66 results
REFINE
SHOW: 16
Climate change increases emergency department visits for heat-related illness in the United States
This research quantifies human-caused climate change's contribution to heat-related illness emergency department visits across the United States. Between 2018 and 2025, climate change contributed approximately 27.1% to the national visit rate, with specific regional impacts exceeding 40% during peak months and significant burdens recorded during major heatwave events.
Turning digital into impact: 10 UNDP country stories
This report details ten UNDP initiatives demonstrating how digital transformation drives social impact. Covering nations like Brazil, India, and Ukraine, it showcases human-centred technological investments that improve justice systems, healthcare delivery, and climate resilience. The findings emphasise that institutional change and trust-building are as critical as the technology itself.
El Niño Heat Mortality Tracker
The El Niño Heat Mortality Tracker projects heat-related deaths at a state and provincial level. Developed by the Climate Impact Lab, it helps users visualise the human toll of extreme temperature events to inform risk assessment and public health strategies.
Women’s health R&I in Europe: Growing investment, persistent gaps, and the case for a coordinated response
This research examines women’s health Research and Innovation (R&I) in Europe, identifying a mismatch between disease burden and investment. While political attention is growing, funding remains concentrated in early-stage research. The report advocates for a coordinated European strategy to bridge evidence and translation gaps across the innovation pathway.
Access to Medicine Foundation Research Hub
The Research Hub is a repository of reports and data on how pharmaceutical companies address global health equity. It offers company profiles, benchmarks, and thematic research to help investors assess ESG performance and access-related risks in the healthcare sector.
Digital sequence information (DSI) on genetic resources: A guide for financial institutions in the context of the Cali Fund
This guide helps financial institutions assess portfolio exposure and engage with companies on digital sequence information (DSI). It outlines regulatory risks, including the Cali Fund and benefit-sharing under the UN Convention on Biological Diversity, while providing practical tools for investor engagement across the pharmaceutical and biotechnology sectors.
Effects of climate change on menstrual health and hygiene: A global mixed-methods systematic review
This systematic review synthesises evidence on how climate change affects menstrual health and hygiene globally. It finds that floods, cyclones, and droughts disrupt access to materials and sanitation, while air pollution correlates with earlier menarche. The report highlights critical gaps in research regarding extreme heat and equity.
The effects of long-term exposure to pollution on health
This research provides causal evidence that long-term exposure to fine particulate matter at contemporary levels increases circulatory morbidity, particularly hypertension. Using a quasi-random assignment of U.S. Army soldiers, the study demonstrates that sustained exposure erodes health capital, even in young, initially healthy populations, highlighting the risks of chronic pollution.
The impact of climate change on human health and pharmaceuticals
This research review examines how climate change and extreme weather increase morbidity across major organ systems. It highlights how rising temperatures and humidity compromise pharmaceutical stability and efficacy, particularly for vulnerable populations. The report calls for updated clinical guidelines and climate-resilient pharmaceutical regulations to safeguard public health.
The Quadripartite Joint Offer: A call for targeted One Health investment
This advocacy document calls for targeted investment in the One Health Joint Plan of Action. The Quadripartite collaboration proposes a Joint Offer to support at least ten countries over five years, strengthening governance, multisectoral coordination, and sustainable financing to prevent and control global health risks effectively.
Financial and economic returns to investing in One Health: Evidence and future directions
This research examines the financial case for investing in One Health to mitigate global health threats. It highlights how integrated approaches reduce costs and improve efficiencies. Through various global case studies, the report demonstrates significant economic returns and provides a strategic blueprint for future sustainable investment.
Old workers, young machines: Can AI and automation offset population ageing?
This report assesses the capacity of artificial intelligence and robots to automate ageing workforces across 135 economies. While automation could offset demographic pressures, its effectiveness is limited because ageing often occurs in sectors with low automation potential, such as health and agriculture, particularly in several fast-ageing advanced economies.
2026 Sustainable investment trends
This report analyses sustainable investment trends for 2026, examining physical climate risk, the energy transition, and Asia’s leadership. It addresses the influence of artificial intelligence on power demand and emission targets, alongside structural challenges in the health care and food production sectors, highlighting resilience and adaptation as key priorities.
Closing the gender health gap: The investment case and capturing Australia's window of opportunity
This report identifies the gender health gap as a systemic market failure and significant investment opportunity. Closing this gap could boost the global economy by US$1 trillion annually by 2040. In Australia, the opportunity is valued at US$24.8 billion per year, offering a time-limited ten-year window for investors.
Where cultivated meat can be sold
An interactive tracker by The Good Food Institute mapping global regulatory approvals and market pathways for cultivated meat products.
State of the Industry: Cultivated meat, seafood, and ingredients series
This benchmark series is an annual State of the Industry series that provides a global overview of the cultivated meat, seafood and ingredients sector. It tracks commercial developments, investment activity, scientific and technological progress, consumer insights, and government and regulatory developments, assessing the sector’s progress towards large-scale commercialisation and adoption.